+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

A

Actively Recruiting

Researchers are evaluating the ADHINCRA Program, a package of evidence-based interventions aimed at improving the control of hypertension among adults aged 18 to 70 in Africa. The program targets factors related to patients, healthcare providers, and health systems to help reduce risks of cardiovascular disease, stroke, and kidney disease. This interventional study is sponsored by Johns Hopkins University and focuses on managing high blood pressure using a nurse-led approach. The ADHINCRA Program includes home blood pressure monitoring, a mobile health application, nurse-led lifestyle counseling, and treatment using a simplified hypertension control protocol. Participants are divided into four cohorts starting the program at staggered intervals immediately, and 3, 6, and 9 months thereafter. All cohorts receive the same intervention to assess its effectiveness and implementation over time. Participants will be monitored for blood pressure control at baseline and at 12 and 24 months after starting the program. Assessments include systolic and diastolic blood pressure measurements, medication adherence via the Hill-Bone Medication Adherence Scale, and evaluation of how well the program is adopted and maintained at clinical sites. Researchers will also compare the cost of this intervention to usual care. The study is planned to end in September 2028, with ongoing safety and adherence monitoring throughout.

Age: 18Years - 70YearsAll GendersPhase Not Applicable
17 locations
T

Actively Recruiting

Lassa fever is a viral hemorrhagic fever causing significant deaths in West Africa, with a 12% in-hospital mortality rate. It spreads mainly through exposure to rodent excreta and sometimes from person to person, leading to hospital outbreaks. Current treatment with ribavirin has concerns about safety, effectiveness, and cost, highlighting the urgent need for new therapies. This multinational phase II-III trial aims to compare new or repurposed drugs against the standard care for hospitalized patients with confirmed Lassa fever. The trial evaluates multiple treatment arms including oral favipiravir at two dosing levels, intravenous ribavirin using the Irrua regimen, combination therapy of favipiravir plus ribavirin, ribavirin with dexamethasone, and two dosing regimens of ARN-75039. Treatments are administered over 10 days during hospitalization. The study uses an open-label, randomized design to compare the efficacy and safety of investigational drugs versus standard care. Participants will be hospitalized for 10 days with follow-up for 28 days. Researchers will assess death, organ failure, and other clinical outcomes such as kidney and respiratory function. Safety and tolerability will be monitored throughout treatment and follow-up. Virological and biological parameters will be measured at multiple time points, along with pharmacokinetics studies. The trial will help determine optimal dosing and compare outcomes across treatment groups over the study period.

Age: 18Years +All GendersPhase 2Phase 3
4 locations
U

Actively Recruiting

This research aims to train radiologists in Nigeria to perform ultrasound-guided breast biopsies for breast cancer diagnosis. The study evaluates the use of mobile health mHealth devices to provide practical and sustainable training for radiologists. This approach is intended to improve the accuracy of breast cancer diagnosis compared to traditional methods used in Nigerian hospitals. Women who have a solid mass on breast ultrasound that is suspicious for breast cancer will be involved in the study. Instead of the usual blind biopsy or surgical excision commonly performed, participants will undergo an ultrasound-guided breast biopsy by trained radiologists using mHealth technology. This procedure is the standard of care in the United States due to its higher accuracy. Participants will be monitored over a one-year period to measure the number of successful ultrasound-guided breast biopsies performed. The study includes assessments related to biopsy procedures and the implementation of this technology into clinical practice. Participant involvement includes undergoing the biopsy procedure and being part of the evaluation of this training methods effectiveness and feasibility.

Age: 18Years +FEMALE
8 locations